Volume Alert - FCX 28.94 Freeport-Mcmoran Inc. $FCX Hit a

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - FCX 28.94 Freeport-Mcmoran Inc. $FCX Hit a high today of 28.98 Closing the day 10:30 at 28.94 +0.51 +1.79% With a day low of 28.48 and a total volume of 2,656,476.

FCX Recent Posts: http://investorshangout.com/Freeport-Mcmoran-...FCX-50979/

FCX Freeport-Mcmoran Inc. Recent Headline News

Watch for Shares of Freeport-McMoRan (FCX) to Approach Resistance at $28.89
Comtex SmarTrend(R) - 1 hr 19 mins ago
Shares of Freeport-McMoRan (NYSE:FCX) opened today above their pivot of $28.28 and have already reached the first level of resistance at $28.66. Analysts will be watching for a cross of the next upside pivot targets of $28.89 and $29.50.
FCX: 28.65 (+0.22)

Peak What? Is It Safe?
The Nattering Naybob - at Seeking Alpha - Wed Nov 12, 7:02AM CST

HK: 3.05 (+0.03), EXXI: 7.10 (+0.13), SLB: 98.76 (+0.40), LNCO: 20.95 (+0.03), SCTY: 51.10 (+0.14), UGAZ: 14.93 (-0.60), PSX: 73.68 (+0.04), EXC: 36.24 (-1.31), REX: 71.25 (+0.93), EOX: 3.04 (-0.07), TPLM: 7.32 (+0.15), HNR: 3.00 (-0.08), CLB: 139.90 (+0.37), CPE: 6.29 (+0.16), PDCE: 43.57 (+0.74), DWTI: 45.95 (-0.64), OAS: 26.80 (+0.18), D: 72.61 (-1.30), KMI: 38.60 (+0.06), F: 14.55 (+0.18), BPZ: 0.93 (-0.02), UNG: 21.79 (-0.29), FCX: 28.65 (+0.22), MXWL: 10.83 (-0.31), UNT: 47.77 (+0.05), ECA: 18.70 (+0.23), QEP: 25.00 (+0.15), TRP: 50.31 (+0.59), CHK: 23.55 (+0.12), DGAZ: 3.43 (+0.13), REN: 2.59 (-0.11), FCG: 15.31 (+0.10), GPRE: 34.03 (-0.24), OIL: 19.02 (+0.10), APA: 75.14 (-0.27), EPL: 37.73 (+0.26), CRZO: 52.34 (+0.62), LINE: 23.55 (+0.20), SYRG: 12.45 (+0.41), PEIX: 14.41 (+0.19), UDNT: 13.17 (+0.10), BHI: 51.80 (+0.32), SN: 17.48 (+0.46), PVA: 9.53 (+0.10), EQU: 5.45 (unch), MHR: 4.86 (+0.15), SLCA: 42.93 (+0.58)

Lower oil prices spark rise in energy bond activity
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 1:36PM CST

CJES: 19.29 (+0.27), FCX: 28.65 (+0.22), COP: 71.80 (+0.05), CVX: 118.52 (+0.08)

Freeport-McMoRan Copper & Gold's (FCX) Management Presents at Cowen Global Metals, Mining and Materials Conference Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 11, 12:51PM CST

FCX: 28.65 (+0.22)

Freeport McMoRan - 32% Drop In Profits As Copper And Oil Prices Spiral Downward
All Bases Covered - at Seeking Alpha - Tue Nov 11, 6:21AM CST

FCX: 28.65 (+0.22)

Freeport-McMoRan Offers More Potential Than Risk
ColoradoWealthManagementFund - at Seeking Alpha - Tue Nov 11, 4:52AM CST

FCX: 28.65 (+0.22)

Freeport-McMoRan Prices $3.0 Billion of Senior Notes
Business Wire - Mon Nov 10, 4:29PM CST
Freeport-McMoRan Inc. (NYSE: FCX) announced today the pricing of $3.0 billion of senior notes. Following is a summary of the four new tranches of debt, which will have an aggregate weighted interest cost of approximately 4.1 percent:
FCX: 28.65 (+0.22)

Commodities Today: Gold Rallies While Solar Fizzles
Matthew Smith - at Seeking Alpha - Fri Nov 07, 10:02AM CST

FSLR: 49.75 (-1.24), ABX: 11.62 (-0.02), KGC: 2.40 (-0.02), FCX: 28.65 (+0.22), AUY: 3.74 (-0.12)

Freeport-McMoRan Will Likely Suffer In The Short Term
IAEResearch - at Seeking Alpha - Thu Nov 06, 4:03PM CST

FCX: 28.65 (+0.22)

InsiderInsights.com Daily Round Up 11/5/14: ELGX, NS, BIOL, NHF
InsiderInsights - at Seeking Alpha - Thu Nov 06, 3:19AM CST

VR: 39.80 (+0.01), JBHT: 80.44 (+0.19), FCX: 28.65 (+0.22), BBY: 34.86 (+0.03), NS: 60.50 (-0.22), LL: 54.98 (-0.52), ELGX: 11.68 (-0.01), ENFC: 13.81 (-0.05), RCL: 67.34 (-0.44), LMCA: 35.76 (-0.12), SPW: 92.71 (-0.32), OPK: 8.37 (-0.16), BIOL: 2.36 (+0.03), IMI: 2.22 (+0.04), NHF: 11.01 (-0.08), SIX: 40.21 (-0.06), TWTR: 39.84 (+0.25), SCHW: 28.84 (-0.01)

Look for Shares of Freeport-McMoRan to Potentially Rebound after Yesterday's 2.37% Sell Off
Comtex SmarTrend(R) - Wed Nov 05, 3:59PM CST
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $27.10 to a high of $27.82. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $27.60 on volume of 15.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 28.65 (+0.22)

Will Commodity Prices Drag Down Apache (APA) Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:50PM CST
Domestic oil and gas explorer Apache Corp. (APA) is set to release its third-quarter 2014 results before the opening bell on Thursday, Nov 6.
CPG: 32.38 (+0.23), FCX: 28.65 (+0.22), APA: 75.14 (-0.27), ROYT: 9.86 (-0.13)

Freeport-McMoRan Down 25.5% Since SmarTrend Downtrend Call (FCX)
Comtex SmarTrend(R) - Wed Nov 05, 11:04AM CST
SmarTrend identified a Downtrend for Freeport-McMoRan (NYSE:FCX) on August 1st, 2014 at $36.95. In approximately 3 months, Freeport-McMoRan has returned 25.54% as of today's recent price of $27.51.
FCX: 28.65 (+0.22)

Freeport-McMoRan (FCX) Approaches New Downside Target of $27.30
Comtex SmarTrend(R) - Wed Nov 05, 8:58AM CST
Freeport-McMoRan (NYSE:FCX) has opened bearishly below the pivot of $27.84 today and has reached the first level of support at $27.55. Analysts will be watching for a cross of the next downside pivot targets of $27.30 and $26.76.
FCX: 28.65 (+0.22)

Freeport Wraps Up Sale of Candelaria Mine Stake for $1.8B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:20PM CST
Freeport-McMoRan Inc. (FCX) said that it has completed the sale of its 80% stake in the Candelaria/Ojos del Salado copper mining operation and supporting infrastructure in Chile to Lundin Mining Corporation for $1.8 billion in cash.
UUUU: 7.75 (+0.17), FCX: 28.65 (+0.22), XPL: 0.95 (-0.02), TC: 2.16 (+0.01)

Stock Market News for November 04, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:10AM CST
Drop in crude prices to over two-year low negated benchmarks’ momentary gains yesterday and they ended almost flat
STLD: 22.38 (+0.21), FCX: 28.65 (+0.22), COP: 71.80 (+0.05), XOM: 96.28 (-0.13), AKS: 6.40 (+0.08), BP: 41.36 (-0.39), MRO: 33.33 (+0.20), CVX: 118.52 (+0.08), X: 35.34 (+0.28)

Why Freeport-McMoRan Is A Great Buying Opportunity
Arie Goren - Seeking Alpha - Tue Nov 04, 6:45AM CST
Freeport-McMoRan (NYSE: FCX ) is an excellent combination of compelling value and strong growth high-yielding dividend stock. FCX's stock has significantly underperformed the market in the last few years. Since the beginning of the year, FCX's stock...
FCX: 28.65 (+0.22)

Alcoa's Investor Day November 4th, And Basic Materials Update
Brian Gilmartin, CFA - Seeking Alpha - Mon Nov 03, 3:25PM CST
Alcoa (NYSE: AA ) is holding an Investor Day on Tuesday, November 4th, and coming into the analyst love-in, the stock is recovering from its sell-off post earnings on October 9th, 2014. When AA reported its 3rd quarter, 2014, results on Wednesday...
1 Comment
F: 14.55 (+0.18), BTU: 11.76 (+0.63), AA: 16.83 (+0.38), FCX: 28.65 (+0.22), X: 35.34 (+0.28)

Freeport-McMoRan Completes Sale of Its Interests in Candelaria/Ojos for $1.8 Billion in Cash
Business Wire - Mon Nov 03, 2:00PM CST
Freeport-McMoRan Inc. (NYSE: FCX) announced today that it has completed its previously announced sale of its 80 percent ownership interest in the Candelaria/Ojos del Salado copper mining operations and supporting infrastructure to Lundin Mining Corporation (TSX:LUN) (Nasdaq OMX:LUMI) for cash consideration of $1.8 billion, before closing adjustments. The transaction has an effective date of June 30, 2014.
FCX: 28.65 (+0.22), LUN.TO: 5.57 (+0.05)

Freeport-Mcmoran Copper & Gold (FCX) Stock Research Links

FCX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading